Lumos Diagnostics Holdings Ltd. (AU:LDX) has released an update.
Lumos Diagnostics Holdings Ltd., a company at the forefront of point-of-care diagnostic technology, has issued a correction for its previously reported financial figures for the March 2024 quarter. The revision pertains to an error in calculating total available funding, which was originally overstated by including a duplicate amount. The corrected cash figures now accurately reflect the company’s financial position for future operations.
For further insights into AU:LDX stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
